In 2008, when Tucker Davis (first row) was diagnosed with fibrolamellar hepatocellular carcinoma (FLC), he founded the Fibrolamellar Cancer Foundation (FCF) with his good friends Alisha Sternenberger, Charles Beermann and Derek Gilchrist (pictured with Tucker.) It was their hope to find a cure for this often fatal disease. Because the incidence of FHC was so rare, little research had been conducted at that time. FCF has helped change that.
FCF’s mission is three-fold:
- Find a cure and treatment options for fibrolamellar
- Raise awareness of this disease
- Connect and support the fibrolamellar community of patients and their families.
FCF’s 10 Year Report, published in October 2020, provides a detailed summary of the significant progress that has been made since the Foundation was incorporated in June 2009. The report outlines the key milestones achieved between 2009 and 2019, discusses the dramatic changes in the fibrolamellar scientific landscape that have occurred, and includes reflections from fighters and their families.
The official video of the Fibrolamellar Cancer Foundation, located below, provides a brief overview of the disease, outlines the history of the organization, and introduces some of the doctors working on fibrolamellar research.
FCF is an IRS approved 501 (c) (3) tax deductible public charity. 100% of net donations go towards research. FCF’s overhead and administrative costs are paid by the Charles A. and Marna Davis Foundation and Stone Point Capital.